Congenital Adrenal Hyperplasia
Last Posted: Jul 20, 2021
- Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years' Experience in the UK.
Buonocore Federica et al. Journal of the Endocrine Society 2021 5(8) bvab086
- Second-tier testing for 21-hydroxylase deficiency in the Netherlands; a newborn screening pilot study.
Stroek Kevin et al. The Journal of clinical endocrinology and metabolism 2021
- The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts.
de Miranda Mirela Costa et al. Frontiers in pediatrics 2021 9659492
- [Newborn screening for congenital adrenal hyperplasia in France].
Kariyawasam Dulanjalee et al. Medecine sciences : M/S 2021 37(5) 500-506
- [The role of Public Health as a key to the success of the neonatal screening program in the Basque Country.]
Espada Sáenz-Torre Mercedes et al. Revista espanola de salud publica 2020 Dec 94
- Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia.
Grosse Scott D et al. International journal of neonatal screening 2020 Oct 6(4)
- Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States.
Edelman Sari et al. International journal of neonatal screening 2020 Aug 6(3)
- Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy.
Held Patrice K et al. International journal of neonatal screening 2020 Aug 6(3)
- CAH Newborn Screening in India: Challenges and Opportunities.
Dabas Aashima et al. International journal of neonatal screening 2020 Aug 6(3)
- Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme.
Lai Fei et al. International journal of neonatal screening 2020 Aug 6(3)
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.